Board of Directors

Adam H. Schechter

Adam H. Schechter has served as Chairman of the Board since May 13, 2020, a director of the Company since April 1, 2013, and as the President and Chief Executive Officer of the Company since November 1, 2019. Mr. Schechter previously served as special advisor to the Chief Executive Officer of Merck & Co., Inc., a pharmaceutical company, from January 2019 to July 2019. Prior to that, Mr. Schechter was an Executive Vice President of Merck, where he w… More >>

Kerrii B. Anderson

Kerrii B. Anderson has served as a director of the Company since May 17, 2006. Ms. Anderson was Chief Executive Officer of Wendy’s International, Inc., a restaurant operating and franchising company, from April 2006 until September 2008, when the company was merged with Triarc. Ms. Anderson served as Executive Vice President and Chief Financial Officer of Wendy’s International from 2000 to 2006. Prior to this position, she was Chief Financial Officer, … More >>

Jean-Luc Bélingard

Jean-Luc Bélingard has served as a director of the Company since April 28, 1995. Mr. Bélingard currently serves as Operating Advisor to Clayton, Dubilier & Rice, a private equity investment firm, since October 2019. From 2011 to December 2017, Mr. Bélingard served as Chairman and CEO of bioMérieux (Président Directeur Général), the worldwide leader of the IVD microbiology segment and a non-US public company. Mr. Bélingard continues to serve on the … More >>

Jeffrey A. Davis

Jeffrey A. Davis has served as a director of the Company since December 1, 2019. Mr. Davis currently serves as the Chief Financial Officer of Qurate Retail Group, a leading retailer and media conglomerate comprised of eight retail brands including QVC, HSN and Zulily, since October 2018. Prior to Qurate Retail Group, Mr. Davis served as Chief Financial Officer of J. C. Penney Company Inc., a retail company, from July 2017 until September 2018. Prior to… More >>

D. Gary Gilliland M.D., Ph.D.

D. Gary Gilliland has served as a director of the Company since April 1, 2014. Dr. Gilliland has served as President and Director Emeritus of the Fred Hutchinson Cancer Research Center, a research organization, in Seattle, WA since January 31, 2020. From January 2, 2015 to January 30, 2020, Dr. Gilliland previously served as President and Director of the Fred Hutchinson Cancer Research Center. Prior to that, he was the inaugural Vice Dean and Vice Pres… More >>

Garheng Kong M.D., Ph.D.

Garheng Kong has served as a director of the Company since December 1, 2013. Dr. Kong is the managing partner of HealthQuest Capital, a healthcare-focused investment firm, a role he has held since he founded HealthQuest Capital in 2012. He was previously a general partner at Sofinnova Capital, a position he held from 2010 to 2013. Before joining Sofinnova, Dr. Kong was a general partner from 2000 to 2010 at Intersouth Partners, a venture capital firm w… More >>

Peter M. Neupert

Peter M. Neupert has served as a director of the Company since January 1, 2013. Mr. Neupert was an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Prior to that, Mr. Neupert served as Corporate Vice President of the Microsoft Health Solutions Group from its formation in 2005 to January 2012. Mr. Neupert served on the President’s Information Technology Advisory Committe… More >>

Richelle P. Parham

Richelle Parham has served as a director of the Company since February 8, 2016. Ms. Parham currently serves as President of Global eCommerce and Business Development for Universal Music Group, a music-based entertainment company, a position she has held since June 2021. In October 2019, Ms. Parham became a Managing Director of WestRiver Group, which provides integrated capital solutions to the global innovation economy with investments focused on techn… More >>

Kathryn E. Wengel

Kathryn E. Wengel has served as a director of the Company since March 25, 2021. Ms. Wengel currently serves as the Executive Vice President, Chief Global Supply Chain Officer, an Executive Committee member, and an Executive Officer of Johnson & Johnson, a leading healthcare company, since July 2018. Since joining Johnson & Johnson in 1988, Ms. Wengel has served in various positions of increasing responsibility across the enterprise both in the … More >>

R. Sanders Williams, M.D.

Dr. R. Sanders Williams has served as a director of the Company since May 16, 2007. Dr. Williams currently serves as Vice President for Research and Innovation (interim) of Duke University. Dr. Williams has served as President Emeritus of The J. David Gladstone Institutes, a non-profit biomedical research enterprise, since January 1, 2018. Prior to this appointment, he was president of The J. David Gladstone Institutes since November 2009, and he serve… More >>